Dr. Rajeev Soni

Dr. Rajeev Soni |Clyto Access

Head of Research and Development, RAS Life Sciences

Keynote Speaker


Biography: Management Expertise: Managing mutli-skilled and mutli-lingual teams across various functions and countries for the past 20 years. Scientific Expertise: Innovative drug discovery research for Cancer and Infectious diseases focusing on both NCE’s and Bio-therapeutics, development of biosimilars, CRAMS (contract research and manufacturing services), fund raising, strategic planning, consulting and business development in the biotech sector. Currently, Head R&D at RAS Life sciences Pvt. Ltd. (a Biomerieux company). Served as Senior Manager, R&D at Novozymes where the role was to lead a group of Scientists researching on various enzymes for different applications. Served as an Associate Vice President at Biocon, Bangalore where the role was to manage molecular biology aspects of various projects and project management of the Glargine project. Founded Premas Biotech, along with a team of entrepreneurs and investors. Served as President and COO since inception. Responsible for in-house and contract research and development. Managed marketing and business development in the beginning. Keen understanding of the life science market in India, Europe and USA. Part of the implementation team for "Lean Management" or the "Toyota production Process" at PREMAS; possibly, one of the first companies in India to implement this in the biology sector coupled with electronic lab-notebook and SDMS for a 21CFR part 11 compliant set up. Successfully delivered over 150 proteins in past 48 months from mg to gm levels. Designed and managed state of the art molecular biology labs at Lidak (Avanir) Pharmaceuticals, La Jolla, USA, De Montfort University, Leicester, U.K., The Naval Research Lab, Washington D.C., USA, Ranbaxy biotechnology, Gurgaon, India and PREMAS, Gurgaon, India.

Related Conferences :

International Biotechnology and Pharmaceutical Industry Forum